Phase 2/3 Metabolic & Obesity Deal Benchmarks
Market Analysis
Phase 2/3 metabolic & obesity licensing deals carry a median total deal value of $4.2B, with upfront payments ranging from $615M to $1.4B. At this stage, deal structures are balanced between upfront and milestone payments, reflecting the proof-of-concept inflection. The recommended split allocates 24% to upfront and 76% to milestones.
The metabolic & obesity landscape at the phase 2/3 stage is characterized by extremely high competitive intensity driven by the GLP-1 revolution and massive obesity market opportunity. Development milestones average $411M, regulatory milestones contribute $633M, and commercial milestones reach $2.2B. Oral formulations, dual/triple incretins, and muscle-sparing approaches command unprecedented deal valuations.
Royalty rates for phase 2/3 metabolic & obesity deals range from 17% to 29.1% at the base tier, with high-tier escalation to 33.1%. Mid-stage royalties reflect the balance of de-risking achieved and remaining development investment.
Full Benchmark Analysis
Complete deal term ranges, comparable transactions, and negotiation insights.
Start 7-Day Free Trial$299/mo after trial · Cancel anytime
Customize these benchmarks for your asset
Adjust phase, modality, competitive position, and 10+ other parameters.
Frequently Asked Questions
What is the average upfront payment for phase 2/3 metabolic & obesity deals?
How are phase 2/3 metabolic & obesity deal milestones structured?
What royalty rates are typical for phase 2/3 metabolic & obesity licensing?
Full Benchmark Analysis
Complete deal term ranges, comparable transactions, and negotiation insights.
Start 7-Day Free Trial$299/mo after trial · Cancel anytime
Ready to Calculate Your Deal Terms?
Get instant, customized benchmarks based on real market data from 1,600+ biopharma licensing deals.
Start CalculatingNeed the full deal landscape?
The Deal Intelligence Brief covers every modality and deal structure for this indication — 52 deal calculations, AI strategic narrative, comparable transactions, partner matching, and white-label branding. Delivered in 24 hours.